Cumberland Interest Debt Per Share from 2010 to 2024

CPIX Stock  USD 1.40  0.03  2.19%   
Cumberland Pharmaceuticals Interest Debt Per Share yearly trend continues to be fairly stable with very little volatility. Interest Debt Per Share will likely drop to 0.50 in 2024. During the period from 2010 to 2024, Cumberland Pharmaceuticals Interest Debt Per Share regression line of annual values had r-squared of  0.54 and arithmetic mean of  0.59. View All Fundamentals
 
Interest Debt Per Share  
First Reported
2010-12-31
Previous Quarter
0.94078031
Current Value
0.5
Quarterly Volatility
0.49346519
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cumberland Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cumberland Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 6.1 M, Interest Expense of 701.3 K or Selling General Administrative of 8.9 M, as well as many indicators such as Price To Sales Ratio of 0.61, Dividend Yield of 0.0 or PTB Ratio of 0.82. Cumberland financial statements analysis is a perfect complement when working with Cumberland Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Cumberland Pharmaceuticals Correlation against competitors.
For more information on how to buy Cumberland Stock please use our How to Invest in Cumberland Pharmaceuticals guide.

Latest Cumberland Pharmaceuticals' Interest Debt Per Share Growth Pattern

Below is the plot of the Interest Debt Per Share of Cumberland Pharmaceuticals over the last few years. It is Cumberland Pharmaceuticals' Interest Debt Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cumberland Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Interest Debt Per Share10 Years Trend
Slightly volatile
   Interest Debt Per Share   
       Timeline  

Cumberland Interest Debt Per Share Regression Statistics

Arithmetic Mean0.59
Geometric Mean0.25
Coefficient Of Variation84.16
Mean Deviation0.44
Median0.50
Standard Deviation0.49
Sample Variance0.24
Range1.2931
R-Value0.73
Mean Square Error0.12
R-Squared0.54
Significance0
Slope0.08
Total Sum of Squares3.41

Cumberland Interest Debt Per Share History

2024 0.5
2023 0.94
2021 1.01
2020 1.15
2019 1.22
2018 1.3
2017 0.62

About Cumberland Pharmaceuticals Financial Statements

Cumberland Pharmaceuticals investors use historical fundamental indicators, such as Cumberland Pharmaceuticals' Interest Debt Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Cumberland Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Interest Debt Per Share 0.94  0.50 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Cumberland Stock Analysis

When running Cumberland Pharmaceuticals' price analysis, check to measure Cumberland Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cumberland Pharmaceuticals is operating at the current time. Most of Cumberland Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cumberland Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cumberland Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cumberland Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.